Clinical Trials Browser

Phase 2 × Cholangiocarcinoma × Ramucirumab × Clear all

NCT02520141 2023-06-15

Ramucirumab in Treating Patients With Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery

Phase 2 Completed

61 enrolled 9 charts

Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma